Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFK7R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,866
Award facts
- Contract value 100% obligated
- $26,866.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,866.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a prescription inhalation medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and does not include a set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical utilizes this contract vehicle to support various federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, ensuring reliable access to essential medications for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FFK7R?
SPE2DR26FFK7R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FFK7R worth?
The government has obligated $26,866 on SPE2DR26FFK7R.
Is contract SPE2DR26FFK7R an order under another contract?
Yes. SPE2DR26FFK7R is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK7R competed?
The extent of competition for SPE2DR26FFK7R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award